Literature DB >> 1700071

Serotonin metabolism by monoamine oxidase in rat primary astrocyte cultures.

L W Fitzgerald1, L Kaplinsky, H K Kimelberg.   

Abstract

The oxidative deamination of serotonin (5-HT) to 5-hydroxyindoleacetic acid (5-HIAA) by rat primary astrocyte cultures was investigated in intact cells using HPLC. All detectable 5-HIAA accumulated in the extracellular medium, and its rate of production was proportional to the 5-HT concentration over the tested range of 5 x 10(-7) to 10(-4) M. At 5 x 10(-7) M 5-HT, intracellular 5-HT was detectable only in astrocytes treated with monoamine oxidase (MAO) inhibitors. These findings are consistent with the idea that 5-HT taken up into astrocytes is not stored for re-release, but is rapidly metabolized to 5-HIAA, which is then extruded from the cell. At 5 x 10(-7) M 5-HT, 5-HIAA formation in intact cells was blocked 63% by the selective high-affinity 5-HT uptake inhibitor fluoxetine. 5-HT oxidation to 5-HIAA is carried out principally by MAO-A, because clorgyline was more effective at inhibiting the production of 5-HIAA than was pargyline. Radioenzymatic determinations of MAO activity in cell homogenates supported these findings, because under these conditions clorgyline was 1,000-fold more effective than pargyline at inhibiting MAO activity toward 14C-labelled 5-HT. However, the relatively selective MAO-B substrate beta-phenylethylamine (PEA) was also oxidized, showing that these cultures also contained MAO-B activity; the Km values for MAO-A oxidation of 5-HT and MAO-B oxidation of PEA were 135 and 45 microM, and Vmax values were 88 and 91 nmol/mg of total cell protein/h, respectively. Higher concentrations of PEA (greater than 20 microM) were oxidized by both MAO-A and MAO-B isozymes.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700071     DOI: 10.1111/j.1471-4159.1990.tb05789.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  14 in total

1.  Moclobemide exerts anti-inflammatory effect in lipopolysaccharide-activated primary mixed glial cell culture.

Authors:  A M Bielecka; M Paul-Samojedny; E Obuchowicz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-09-02       Impact factor: 3.000

2.  Ultrastructural localization of the serotonin transporter in limbic and motor compartments of the nucleus accumbens.

Authors:  V M Pickel; J Chan
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

3.  Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat.

Authors:  P Celada; F Artigas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-06       Impact factor: 3.000

4.  In vivo evidence for the reversible action of the monoamine oxidase inhibitor brofaromine on 5-hydroxytryptamine release in rat brain.

Authors:  N Bel; F Artigas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-05       Impact factor: 3.000

5.  Brain microdialysis in rats: a technique to reveal competition in vivo between endogenous dopamine and moclobemide, a RIMA antidepressant.

Authors:  A Colzi; F d'Agostini; A M Cesura; M Da Prada
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  The pro-inflammatory cytokine TNF-α regulates the activity and expression of the serotonin transporter (SERT) in astrocytes.

Authors:  Sandra Malynn; Antonio Campos-Torres; Paul Moynagh; Jana Haase
Journal:  Neurochem Res       Date:  2013-01-22       Impact factor: 3.996

7.  Uptake and metabolism of serotonin by ependymal primary cultures.

Authors:  Stephan Verleysdonk; Bernd Hamprecht; Mirna Rapp; John Wellard
Journal:  Neurochem Res       Date:  2004-09       Impact factor: 3.996

Review 8.  Gliogenesis and glial pathology in depression.

Authors:  G Rajkowska; J J Miguel-Hidalgo
Journal:  CNS Neurol Disord Drug Targets       Date:  2007-06       Impact factor: 4.388

Review 9.  Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue.

Authors:  Grazyna Rajkowska; Craig A Stockmeier
Journal:  Curr Drug Targets       Date:  2013-10       Impact factor: 3.465

10.  Systemic phencyclidine administration is associated with increased dopamine, GABA, and 5-HIAA levels in the dorsolateral striatum of conscious rats: an in vivo microdialysis study.

Authors:  S M Lillrank; W T O'Connor; S S Oja; U Ungerstedt
Journal:  J Neural Transm Gen Sect       Date:  1994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.